Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AB-521 by Arcus Biosciences for Renal Cell Carcinoma: Likelihood of Approval
AB-521 is under clinical development by Arcus Biosciences and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...
Data Insights
AB-521 by Arcus Biosciences for Solid Tumor: Likelihood of Approval
AB-521 is under clinical development by Arcus Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase...